Special items: Ovarian Cancer and Us blog best viewed in Firefox

Tuesday, May 11, 2010

EntreMed adds DF/HCC hospitals to Phase 2 study of ENMD-2076 for platinum resistant ovarian cancer

No comments:

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.